Evidence map›Paper›PMID 21889442›Full record

ArticleBiophysical journal2011

Rectification of the channelrhodopsin early conductance.

Dietrich Gradmann, André Berndt, Franziska Schneider, Peter Hegemann

Abstract read
In one paragraph

Article in Biophysical journal, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed.

  1. Article
  2. Structural Insights Into the Opening Mechanism of C1C2 Channelrhodopsin.Journal of the American Chemical Society · 2025
    Article
  3. Potassium-selective channelrhodopsins.Biophysics and physicobiology · 2023
    Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Molecular properties of a DTD channelrhodopsin fromBiophysics and physicobiology · 2017
    Article
  15. Article
  16. Article
  17. Proteomonas sulcata ACR1: A Fast Anion Channelrhodopsin.Photochemistry and photobiology · 2016
    Article
  18. PyRhO: A Multiscale Optogenetics Simulation Platform.Frontiers in neuroinformatics · 2016
    Article
  19. Article
  20. Gating mechanisms of a natural anion channelrhodopsin.Proceedings of the National Academy of Sciences of the United States of America · 2015
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Dietrich GradmannA.-v.-Haller-Institut der Universität, Göttingen, Germany. dgradma@gwdg.de
André Berndt
Franziska Schneider
Peter Hegemann

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We analyzed the nonlinear current-voltage relationships of the early conducting state of channelrhodopsin-2 expressed in Xenopus oocytes and human embryonic kidney cells with respect to changes of the electrochemical gradients of H(+), Na(+)/K(+), and Ca(2+)/Mg(2+). Several models were tested for wild-type ChR2 and mutations at positions E90, E123, H134, and T159. Voltage-gating was excluded as cause for the nonlinearity. However, a general enzyme kinetic model with one predominant binding site yielded good fits throughout. The empty site with an apparent charge number of about -0.3 and strong external cation binding causes some inward rectification of the uniport function. Additional inward rectification is due to asymmetric competition from outside between the transported ion species. Significant improvement of the fits was achieved by introducing an elastic voltage-divider formed by the voltage-sensitive barriers.

Indexed as

Electric ConductivityModels, BiologicalAnimalsCations, DivalentHEK293 CellsHumansKineticsMutationNonlinear DynamicsRhodopsins, MicrobialCations, DivalentRhodopsins, Microbial

Identifiers

PMID21889442
PMCPMC3325117

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.